RecruitingNot ApplicableNCT05200351
Equine-assisted Therapy for Therapy-resistant Adolescents With Autism Spectrum Disorders, a Replicated AB-design
Sponsor
Karakter Kinder- en Jeugdpsychiatrie
Enrollment
35 participants
Start Date
Feb 14, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to assess the (cost)effectivity of Equine assisted Therapy in adolescents with Autism Spectrum disorders.
Eligibility
Min Age: 11 YearsMax Age: 18 Years
Inclusion Criteria4
- between 11-18 years old;
- a clinical diagnosis of autism spectrum disorders according the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM 5) as diagnosed by a Beroepen in de Individuele Gezondheidszorg (BIG) registered healthcare professional;
- insufficient emotion regulation after regular therapy for at least 1,5 years as indicated by a score above clinical cut-off (T-score = 65) on the EDI;
- comorbidities are allowed except for those interfering with safety.
Exclusion Criteria9
- unable to respond to questions (parents or adolescents);
- no access to an Internet connection;
- insufficient mastery of Dutch language in parents or adolescents;
- physically incapable to work with the horses;
- unstable medication use;
- total intelligence quotient (IQ) equal to or below 80 on the Wechsler Intelligence Scale for Children (WISC-III-R or WISC-V);
- allergic or phobic to horses;
- insufficient regulation to safely handle the horses;
- therapy with horses within the last two years.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALEquine assisted Therapy (EAT)
15 sessions of EAT will be given. Activities will be with or in the presence of the horse. There will be no horseriding.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05200351
Related Trials
Behavior Analytic Support of Needle-related Hospital Visits for Autistic Patients
NCT067127841 location
Internet-based Talking About Risk and Adolescent Choices: Health and Emotion Regulation Options
NCT068942771 location
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
NCT070912792 locations
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
NCT059992402 locations
Speech Treatment for Minimally Verbal Children With ASD and CAS
NCT050661781 location